Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 17

1.

Cyanine-Gemcitabine Conjugates as Targeted Theranostic Agents for Glioblastoma Tumor Cells.

Jiang Z, Pflug K, Usama SM, Kuai D, Yan X, Sitcheran R, Burgess K.

J Med Chem. 2019 Oct 24;62(20):9236-9245. doi: 10.1021/acs.jmedchem.9b01147. Epub 2019 Oct 11.

PMID:
31469566
2.

Conjugation of Dasatinib with MHI-148 Has a Significant Advantageous Effect in Viability Assays for Glioblastoma Cells.

Usama SM, Jiang Z, Pflug K, Sitcheran R, Burgess K.

ChemMedChem. 2019 Sep 4;14(17):1575-1579. doi: 10.1002/cmdc.201900356. Epub 2019 Aug 7.

PMID:
31322832
3.

NIK/MAP3K14 Regulates Mitochondrial Dynamics and Trafficking to Promote Cell Invasion.

Jung JU, Ravi S, Lee DW, McFadden K, Kamradt ML, Toussaint LG, Sitcheran R.

Curr Biol. 2016 Dec 19;26(24):3288-3302. doi: 10.1016/j.cub.2016.10.009. Epub 2016 Nov 23.

4.

NIK regulates MT1-MMP activity and promotes glioma cell invasion independently of the canonical NF-κB pathway.

Duran CL, Lee DW, Jung JU, Ravi S, Pogue CB, Toussaint LG, Bayless KJ, Sitcheran R.

Oncogenesis. 2016 Jun 6;5(6):e231. doi: 10.1038/oncsis.2016.39.

5.
6.

The NF-κB RelB protein is an oncogenic driver of mesenchymal glioma.

Lee DW, Ramakrishnan D, Valenta J, Parney IF, Bayless KJ, Sitcheran R.

PLoS One. 2013;8(2):e57489. doi: 10.1371/journal.pone.0057489. Epub 2013 Feb 25.

7.

IKK-dependent, NF-κB-independent control of autophagic gene expression.

Comb WC, Cogswell P, Sitcheran R, Baldwin AS.

Oncogene. 2011 Apr 7;30(14):1727-32. doi: 10.1038/onc.2010.553. Epub 2010 Dec 13.

8.

Ex vivo inhibition of NF-kappaB signaling in alloreactive T-cells prevents graft-versus-host disease.

O'Shaughnessy MJ, Vogtenhuber C, Sun K, Sitcheran R, Baldwin AS, Murphy WJ, Dang L, Jaffee B, Palmer E, Serody JS, Blazar BR.

Am J Transplant. 2009 Mar;9(3):452-62. doi: 10.1111/j.1600-6143.2008.02533.x.

9.

Blimp-1/PRDM1 mediates transcriptional suppression of the NLR gene NLRP12/Monarch-1.

Lord CA, Savitsky D, Sitcheran R, Calame K, Wright JR, Ting JP, Williams KL.

J Immunol. 2009 Mar 1;182(5):2948-58. doi: 10.4049/jimmunol.0801692.

10.

Essential role for epidermal growth factor receptor in glutamate receptor signaling to NF-kappaB.

Sitcheran R, Comb WC, Cogswell PC, Baldwin AS.

Mol Cell Biol. 2008 Aug;28(16):5061-70. doi: 10.1128/MCB.00578-08. Epub 2008 Jun 9.

11.

Loss of epithelial RelA results in deregulated intestinal proliferative/apoptotic homeostasis and susceptibility to inflammation.

Steinbrecher KA, Harmel-Laws E, Sitcheran R, Baldwin AS.

J Immunol. 2008 Feb 15;180(4):2588-99.

12.

Positive and negative regulation of EAAT2 by NF-kappaB: a role for N-myc in TNFalpha-controlled repression.

Sitcheran R, Gupta P, Fisher PB, Baldwin AS.

EMBO J. 2005 Feb 9;24(3):510-20. Epub 2005 Jan 20.

13.

Nuclear factor-kappaB is an important modulator of the altered gene expression profile and malignant phenotype in squamous cell carcinoma.

Loercher A, Lee TL, Ricker JL, Howard A, Geoghegen J, Chen Z, Sunwoo JB, Sitcheran R, Chuang EY, Mitchell JB, Baldwin AS Jr, Van Waes C.

Cancer Res. 2004 Sep 15;64(18):6511-23. Erratum in: Cancer Res. 2004 Nov 1;64(21):8130-2.

14.

Inhibition of acute graft-versus-host disease with retention of graft-versus-tumor effects by the proteasome inhibitor bortezomib.

Sun K, Welniak LA, Panoskaltsis-Mortari A, O'Shaughnessy MJ, Liu H, Barao I, Riordan W, Sitcheran R, Wysocki C, Serody JS, Blazar BR, Sayers TJ, Murphy WJ.

Proc Natl Acad Sci U S A. 2004 May 25;101(21):8120-5. Epub 2004 May 17. Erratum in: Proc Natl Acad Sci U S A. 2004 Aug 24;101(34):12777.

15.
17.

Topographic organization of sensory projections to the olfactory bulb.

Vassar R, Chao SK, Sitcheran R, Nuñez JM, Vosshall LB, Axel R.

Cell. 1994 Dec 16;79(6):981-91.

PMID:
8001145

Supplemental Content

Loading ...
Support Center